Prohibited Substance cases under FEI anti-doping rules 

23 Mar 2018

The FEI Tribunal has issued its Final Decision on the case opened by the FEI against Italian Jumping athlete Giacomo Basso (FEI ID 10035513/ITA) following a positive for the two Prohibited Substances Stanozolol and Ketoprofen. Stanozol is a *Banned Substance and Ketoprofen is a Controlled Medication under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

Samples taken from the horse Cenerado at the CSI3* at Gorla Minore (ITA) on 12 March 2017 returned positive for the two substances and the athlete was provisionally suspended on 5 April 2017. The horse was also provisionally suspended for two months.

In its final decision, the FEI Tribunal imposed a two-year suspension on the athlete, starting from the date of sample collection and running through to 11 March 2019. The FEI Tribunal also imposed a fine of CHF 4,000 and ordered the athlete to contribute CHF 2,500 towards the costs of the judicial procedure, plus the cost of the B-Sample analysis.

The Final Decision is available here. The athlete has 21 days from the date of notification (23 March 2018) to appeal the decision to the Court of Arbitration for Sport.

Separately, the FEI has also announced new adverse analytical findings involving equine prohibited substances.

The cases involve the use of *Banned Substances under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

The athletes have been provisionally suspended from the date of notification until the FEI Tribunal renders its decisions. The horses have been provisionally suspended for two months.


Horse: Flor Del Caribe (FEI ID 105BN98/UAE)

Person Responsible: Federica Rossi (FEI ID 10066438/ARG)

Event: CEI3* 160 - Abu Dhabi, Al Wathba (UAE)

Date of Event: 10/02/2018

Prohibited Substance(s): GW1516, GW1516 Sulphone

Date of notification: 19 March 2018


Horse: Bolota De Alcantara (FEI ID 105MF17/POR)

Person Responsible: Rodrigo Picão Abreu (FEI ID 10064534/POR)

Event: CEI2* 120 Reguengos de Monsaraz (POR)

Date of Event: 17/02/2018

Prohibited Substance(s): O-Desmethyl Venlafaxine

Date of notification: 19 March 2018


Horse: Tina La Boheme (FEI ID 104IJ07/USA)

Person Responsible: Mohammed Ahmed Al Owais (FEI ID 10040940/UAE)

Event: CSI2* - Abu Dhabi (UAE)

Date of Event: 14/02/2018 - 17/02/2018

Prohibited Substance(s): Diisopropylamine

Date of notification: 19 March 2018


Horse: Sohair Des Bruyere (FEI ID 104VK62/QAT)

Person Responsible: Elizaveta Minina (FEI ID 10140497/RUS)

Event: CEI2* 120 - Doha, Mesaieed (QAT)

Date of Event: 20/01/2018

Prohibited Substance(s): Testosterone

Date of notification: 5 March 2018


Details on these cases can be found here and here. Information on the substances is available on the searchable FEI Equine Prohibited Substances Database.


*Notes to Editors:

The FEI’s Prohibited Substances List is divided into two sections - Controlled Medication and *Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) substances should never be found in the body of the horse.

In the case of an adverse analytical finding for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification. The horse is suspended for two months.

The FEI has also introduced the concept of Specified Substances. Specified Substances should not in any way be considered less important or less dangerous than other Prohibited Substances. Rather, they are simply substances which are more likely to have been ingested by horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance. In the case of a positive for a specified substance, provisional suspension is not automatic.